Targeting Cardiovascular Adverse Events of Metastatic Renal Cell Carcinoma Therapies
JACC CardioOncol
.
2022 Jun 21;4(2):235-237.
doi: 10.1016/j.jaccao.2022.05.007.
eCollection 2022 Jun.
Authors
Avirup Guha
1
2
,
Nicolas Sayegh
3
,
Neeraj Agarwal
3
Affiliations
1
Cardio-Oncology Program, Georgia Cancer Center, Medical College of Georgia at Augusta University, Augusta, Georgia, USA.
2
Division of Cardiovascular Disease, Department of Medicine, Medical College of Georgia at Augusta University, Augusta, Georgia, USA.
3
Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.
PMID:
35818554
PMCID:
PMC9270611
DOI:
10.1016/j.jaccao.2022.05.007
No abstract available
Keywords:
metastatic renal cell carcinoma; preventive cardiology; tyrosine kinase inhibitors.
Publication types
Editorial